SSIF Annual meeting in multiple sclerosis

9 May 2014 to 10 May 2014


Symposia website:

Aim of the conference

Multiple sclerosis is one of the most disabling neurological disorders and has a significant impact on the lives of young adults, the age group that is most affected. Even though the scientific discoveries of recent decades have improved both diagnostic capability and the therapeutic opportunities, there are still open questions. The medical approach has changed from disease-oriented to patient-centred as a result of the patients' need to be involved in the decision making process and the opportunity to better tailor treatment based on the disease activity. The aim of the conference will be to explore the roles of genetics and environment in the pathogenesis of MS and examine options within the patient-centred approach to clinical management.

Learning objectives

By attending the live educational conference learners will be able to:

  • Describe the latest advances in MS pathogenesis
  • Explain the role of genetic susceptibility and environment in MS pathogenesis
  • Select the most suitable treatment on the basis of disease phase
  • Identify the main predictors of disease evolution
  • Summarize how to assess non responders to treatment and how to change therapies

Target audience

Neurologists involved in the management of MS patients.


An application will be made to the EACCME® for CME accreditation of the 2014 SSIF Annual conference "Multiple sclerosis: improving patient outcomes through scientific and clinical advances" to be held on 9-10 May 2014 in Dubai, UAE.

Serono Symposia International Foundation (SSIF) adheres to the principles of the Good CME Practice Group (gCMEp).


Meridiano Congress International
Via Sapri, 6 - 00185 Rome, Italy

Senior project manager and team leader: Sara Guglielmini

Tel.: +39 (0)6 88 595 211
Fax: +39 (0)6 88595 234

JW Marriott Marquis
Sheikh Zayed Road
Business Bay
United Arab Emirates